Clinical Trial

Testing Experimental Medication in Healthy Subjects

Study Description

A Study of LY3478006 in Healthy Participants

The purpose of this study is to learn more about how safe and how well tolerated LY3478006 is when given by injection into a vein or just under the skin to healthy participants. Blood tests will be done to check how much LY3478006 is in the bloodstream and how long the body takes to get rid of it. For each participant, the study will last up to about 16 weeks, including screening.

Location

Locations Selected Location

Methods

Pharmaceutical medication involved Pharmaceutical medication involved
Patients and healthy individuals accepted Patients and healthy individuals accepted

Drug - LY3478006 - IV

Administered IV

Drug - LY3478006 - SC

Administered SC

Drug - Placebo - IV

Administered IV

Drug - Placebo - SC

Administered SC

Additional Information

Official Study Title

A Single Ascending Dose Study to Evaluate Safety, Tolerability, and Pharmacokinetics of LY3478006 in Healthy Subjects

Clinical Trial ID

NCT04230122

ParticipAid ID

aKrgze